HOME >> BIOLOGY >> NEWS
Enzyme maintaining chromosome ends is linked to bone cancer recurrence, decreased survival

Children with the bone tumor osteosarcoma are more likely to experience a recurrence of the cancer after treatment and less likely to survive if the cancer cells are expressing the telomerase gene. This finding, from investigators at St. Jude Children's Research Hospital, appears in the current issue of the Journal of Clinical Oncology (JCO).

Osteosarcoma is the most common primary bone tumor in children. Primary tumors are those originating in a specific place in the body rather than those that have spread from elsewhere. About 30 percent of children with osteosarcoma that has not spread from the bone and 60 percent of those whose tumors have spread do not survive.

"Overall, our results indicate that telomerase gene expression is associated with an unfavorable outcome for children being treated for osteosarcoma," said Jeffrey S. Dome, M.D., associate member in Hematology-Oncology at St. Jude. Dome is senior author of the JCO report. Robert P. Sanders, M.D., a St. Jude postdoctoral fellow, is the paper's first author.

Although study results are preliminary, they might lead to tests that could identify children at high risk for treatment failure or death. That could help physicians determine how to modify therapies to improve chances of success in the future. The findings were based on a retrospective study of samples taken from osteosarcoma tumors of children treated at St. Jude during a 20-year period.

Telomerase is an enzyme that helps cancer cells survive and proliferate. The enzyme builds and maintains caps called telomeres that are located on the ends of chromosomes. These telomeres protect the chromosome ends from damage that otherwise would trigger apoptosis--the cell's self-destruct program.

Most cancers activate telomerase to maintain telomeres in order to protect their chromosomes and ensure the cells survive and multiply.

However, a minority of cancers use a poorly understood mechanism called "alternativ
'"/>

Contact: Bonnie Cameron
bonnie.cameron@stjude.org
901-495-4815
St. Jude Children's Research Hospital
23-Sep-2004


Page: 1 2 3

Related biology news :

1. Enzyme activation appears key in helping internal clock tell night from day
2. Enzyme fully degrades mad cow disease prion
3. Enzyme revealed that is key to funguss ability to breach immune system
4. Enzyme discovery sheds light on causes of rare disease, cancer
5. Enzyme could overcome industrial bleaching waste problems
6. Enzyme controls good cholesterol
7. Enzyme discovery to benefit homeland security, industry
8. Enzyme could aid cancer fight
9. Enzyme once thought harmful to Alzheimers patients now appears key to future treatment
10. Enzyme mimetic reduces tissue damage in colitis animal study
11. Enzyme studies at Brookhaven Lab may lead to new antiviral agents

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/16/2019)... ... June 14, 2019 , ... ... customer, will deliver a joint presentation with Versiti’s CIO at the Healthcare ... the Rosen Shingle Creek Resort. , Versiti Vice President and Chief Information Officer, ...
(Date:6/11/2019)... ... June 10, 2019 , ... Improved Pharma LLC announces ... 2019 issue of AAPS PharmSciTech. The article was published online on April 29th, 2019. ... Pharma, along with Xiaoming Sean Chen of Purdue University. , The article is the ...
(Date:6/4/2019)... ... June 04, 2019 , ... ... appointment of Susan Murphy as the new President of Molecular Devices, replacing Greg ... Devices’ parent company, Danaher Corporation. , Since joining Molecular Devices in a scientific ...
Breaking Biology News(10 mins):
(Date:5/31/2019)... ... May 30, 2019 , ... ... on Data Integrity on July 08-09, 2019 in Boston, MA. This peer recommended ... medical device organizations. , The training will kick off with a compendial treatment ...
(Date:5/15/2019)... , ... May 15, 2019 , ... Milton Hershey School® ... recognition for his work within the biomedical industry, where he is changing lives by ... devices. , “William Harding epitomizes the vision of our founders – Milton and ...
(Date:5/7/2019)... ... May 06, 2019 , ... "The new ... number of repositories being asked to store cellular products being used in ... contributors who are world leaders, who have shared their expertise in building and ...
(Date:5/2/2019)... ... May 02, 2019 , ... Stay on top of ... device and food industries. Access to all webinars is free, so be sure to ... your field! , Visit http://www.xtalks.com to see our upcoming webinars: , CLINICAL ...
Breaking Biology Technology:
Cached News: